Evergreen Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Evergreen Capital Management's CORT Position: Q3 2026 in Review
Evergreen Capital Management increased its Corcept Therapeutics (CORT) stake by 0.21% in Q3 2026, buying an estimated $2.04K and bringing the position to 9,033 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #494.
Evergreen Capital Management first reported a position in CORT in Q4 2023 and has held it in 11 quarters since. 403 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Evergreen Capital Management held 9,033 shares of Corcept Therapeutics worth $1.04M as of Q3 2026.
- Evergreen Capital Management bought 19 Corcept Therapeutics shares in Q3 2026, an estimated $2.04K.
- Corcept Therapeutics made up 0.02% of Evergreen Capital Management's portfolio in Q3 2026, its #494 holding.
- Evergreen Capital Management first reported a position in Corcept Therapeutics in Q4 2023 and has held it in 11 quarters since.
- 403 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Evergreen Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.